These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 9266616)

  • 1. Different behavioral effects of daily or intermittent dexamphetamine administration in Nijmegen high and low responders.
    Gingras MA; Cools AR
    Psychopharmacology (Berl); 1997 Jul; 132(2):188-94. PubMed ID: 9266616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No major differences in locomotor responses to dexamphetamine in high and low responders to novelty: a study in Wistar rats.
    Gingras MA; Cools AR
    Pharmacol Biochem Behav; 1997 Aug; 57(4):857-62. PubMed ID: 9259016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in vulnerability and susceptibility to dexamphetamine in Nijmegen high and low responders to novelty: a dose-effect analysis of spatio-temporal programming of behaviour.
    Cools AR; Ellenbroek BA; Gingras MA; Engbersen A; Heeren D
    Psychopharmacology (Berl); 1997 Jul; 132(2):181-7. PubMed ID: 9266615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioural consequences of withdrawal from three different administration schedules of amphetamine.
    Russig H; Murphy CA; Feldon J
    Behav Brain Res; 2005 Nov; 165(1):26-35. PubMed ID: 16157394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the biphasic locomotor response to ethanol in high and low responders to novelty: a study in Nijmegen Wistar rats.
    Gingras MA; Cools AR
    Psychopharmacology (Berl); 1996 Jun; 125(3):258-64. PubMed ID: 8815962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences between dextroamphetamine and methamphetamine: behavioral changes and oxidative damage in brain of Wistar rats.
    da-Rosa DD; Valvassori SS; Steckert AV; Arent CO; Ferreira CL; Lopes-Borges J; Varela RB; Mariot E; Dal-Pizzol F; Andersen ML; Quevedo J
    J Neural Transm (Vienna); 2012 Jan; 119(1):31-8. PubMed ID: 21858431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nijmegen high and low responders to novelty: a new tool in the search after the neurobiology of drug abuse liability.
    Cools AR; Gingras MA
    Pharmacol Biochem Behav; 1998 May; 60(1):151-9. PubMed ID: 9610937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of unconditioned novelty-seeking and d-amphetamine-conditioned motivation in mice.
    Laviola G; Adriani W
    Pharmacol Biochem Behav; 1998 Apr; 59(4):1011-20. PubMed ID: 9586862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amphetamine withdrawal modulates FosB expression in mesolimbic dopaminergic target nuclei: effects of different schedules of administration.
    Murphy CA; Russig H; Pezze MA; Ferger B; Feldon J
    Neuropharmacology; 2003 Jun; 44(7):926-39. PubMed ID: 12726824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inbred Lewis and Fischer 344 rat strains differ not only in novelty- and amphetamine-induced behaviors, but also in dopamine transporter activity in vivo.
    Gulley JM; Everett CV; Zahniser NR
    Brain Res; 2007 Jun; 1151():32-45. PubMed ID: 17395161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Individual differences in amphetamine sensitization: dose-dependent effects.
    Hooks MS; Jones GH; Neill DB; Justice JB
    Pharmacol Biochem Behav; 1992 Jan; 41(1):203-10. PubMed ID: 1539070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioral sensitization following concurrent exposure to mephedrone and D-amphetamine in female mice.
    Berquist MD; Peet MM; Baker LE
    Behav Pharmacol; 2015 Feb; 26(1-2):180-3. PubMed ID: 25485643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Individual responses to novelty predict qualitative differences in d-amphetamine-induced open field but not reward-related behaviors in rats.
    Antoniou K; Papathanasiou G; Panagis G; Nomikos GG; Hyphantis T; Papadopoulou-Daifoti Z
    Neuroscience; 2004; 123(3):613-23. PubMed ID: 14706774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-lasting effects of escalating doses of d-amphetamine on brain monoamines, amphetamine-induced stereotyped behavior and spontaneous nocturnal locomotion.
    Robinson TE; Camp DM
    Pharmacol Biochem Behav; 1987 Apr; 26(4):821-7. PubMed ID: 2440058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Individual differences in novelty-seeking behavior in spontaneously hypertensive rats: Enhanced sensitivity to the reinforcing effect of methylphenidate in the high novelty-preferring subpopulation.
    dela Peña I; Gonzales EL; de la Peña JB; Kim BN; Han DH; Shin CY; Cheong JH
    J Neurosci Methods; 2015 Aug; 252():48-54. PubMed ID: 25169048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of continuous D-amphetamine and phencyclidine administration on social behaviour, stereotyped behaviour, and locomotor activity in rats.
    Sams-Dodd F
    Neuropsychopharmacology; 1998 Jul; 19(1):18-25. PubMed ID: 9608573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects on prepulse inhibition of withdrawal from two different repeated administration schedules of amphetamine.
    Peleg-Raibstein D; Sydekum E; Feldon J
    Int J Neuropsychopharmacol; 2006 Dec; 9(6):737-49. PubMed ID: 16448582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitization to amphetamine on the differential-reinforcement-of-low-rate 72-s schedule.
    Balcells-Olivero M; Richards JB; Seiden LS
    Psychopharmacology (Berl); 1997 Oct; 133(3):207-13. PubMed ID: 9361325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Striatal dopamine sensitization to D-amphetamine in periadolescent but not in adult rats.
    Laviola G; Pascucci T; Pieretti S
    Pharmacol Biochem Behav; 2001 Jan; 68(1):115-24. PubMed ID: 11274716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentially altered mGluR1 and mGluR5 mRNA expression in rat caudate nucleus and nucleus accumbens in the development and expression of behavioral sensitization to repeated amphetamine administration.
    Mao L; Wang JQ
    Synapse; 2001 Sep; 41(3):230-40. PubMed ID: 11418936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.